Kaplan Medical Center

Futó vizsgálatok

• Toboroz

  A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis

  NCT07470879· 2. fázis· Pfizer· Forrás

• Fut, nem toboroz

  COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

  NCT07449936· 3. fázis· EyePoint Pharmaceuticals, Inc.· Forrás

• Toboroz

  A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

  NCT07392190· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

  NCT07222137· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

  NCT07284459· 2. fázis· Contineum Therapeutics· Forrás

• Toboroz

  A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

  NCT07241390· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

  NCT07007065· 3. fázis· AbbVie· Forrás

• Toboroz

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

  NCT07064759· 3. fázis· 4D Molecular Therapeutics· Forrás

• Még nem toboroz

  Iron Deficiency in Pediatric Celiac Disease: Diet vs. Iron Supplementation Trial

  NCT06921343· Kaplan Medical Center· Forrás

• Fut, nem toboroz

  A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56

  NCT06683742· 3. fázis· EyePoint Pharmaceuticals, Inc.· Forrás

• Fut, nem toboroz

  Intra-articular Allocetra in Osteoarthritis of the 1st Carpo-metacarpal Joint

  NCT06459063· 1/2. fázis· Kaplan Medical Center· Forrás

• Fut, nem toboroz

  A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C

  NCT05975021· 1/2. fázis· Windtree Therapeutics· Forrás

• Fut, nem toboroz

  The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

  NCT06383390· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  NCT05485961· 2/3. fázis· CSL Behring· Forrás

• Toboroz

  A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

  NCT05923073· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

  NCT05509777· 3. fázis· Eli Lilly and Company· Forrás

• Fut, nem toboroz

  A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer

  NCT06012435· 3. fázis· Seagen, a wholly owned subsidiary of Pfizer· Forrás

• Toboroz

  Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

  NCT05696626· 3. fázis· LeonaBio· Forrás

• Toboroz

  Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  NCT05943535· 3. fázis· United Therapeutics· Forrás

• Fut, nem toboroz

  Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes

  NCT06008756· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Fut, nem toboroz

  A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

  NCT06052267· 3. fázis· Teva Branded Pharmaceutical Products R&D LLC· Forrás

• Fut, nem toboroz

  Use of Allocetra-OTS in End Stage Knee Osteoarthritis - Assessment of Safety

  NCT06208241· Korai 1. fázis· Amir Oron· Forrás

• Toboroz

  A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

  NCT05878769· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

  NCT05716100· 3. fázis· Xenon Pharmaceuticals Inc.· Forrás

• Meghívásos bevonás

  An Open-label Study of XEN1101 in Epilepsy

  NCT05718817· 3. fázis· Xenon Pharmaceuticals Inc.· Forrás

• Toboroz

  POST URS Chemotherapy Instillation

  NCT06167057· Carmel Medical Center· Forrás

• Fut, nem toboroz

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· 3. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

  NCT05445778· 3. fázis· AbbVie· Forrás

• Fut, nem toboroz

  A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer

  NCT05654623· 3. fázis· Pfizer· Forrás

• Toboroz

  A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

  NCT05667142· 3. fázis· Xenon Pharmaceuticals Inc.· Forrás

• Toboroz

  Safety and Performance Evaluation of the Nephronyx System for the Treatment of Patients With ADHF

  NCT05759806· Nephronyx LTD· Forrás

• Meghívásos bevonás

  An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

  NCT05667493· 3. fázis· Ionis Pharmaceuticals, Inc.· Forrás

• Fut, nem toboroz

  A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

  NCT05556512· 3. fázis· Eli Lilly and Company· Forrás

• Fut, nem toboroz

  A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT05242484· 2. fázis· Janssen Research & Development, LLC· Forrás

• Meghívásos bevonás

  Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease

  NCT04905693· 3. fázis· United Therapeutics· Forrás

• Fut, nem toboroz

  A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes

  NCT05433584· 4. fázis· Eli Lilly and Company· Forrás

• Fut, nem toboroz

  Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

  NCT05382286· 3. fázis· Gilead Sciences· Forrás

• Fut, nem toboroz

  A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT05242471· 2. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

  NCT05382299· 3. fázis· Gilead Sciences· Forrás

• Fut, nem toboroz

  A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease

  NCT05197049· 3. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  NCT05089734· 3. fázis· Gilead Sciences· Forrás

• Toboroz

  ContraBand™: Safety & Feasibility Study (RM-20-01)

  NCT05230745· Restore Medical Ltd· Forrás

• Fut, nem toboroz

  A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

  NCT04965493· 3. fázis· Loxo Oncology, Inc.· Forrás

• Fut, nem toboroz

  A Study of the Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)

  NCT04657289· 3. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  Study to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Psoriasis Treated With Subcutaneous Risankizumab Injection According to Standard of Care

  NCT04780516· AbbVie· Forrás

• Fut, nem toboroz

  A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

  NCT04576156· 3. fázis· Geron Corporation· Forrás

• Toboroz

  Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

  NCT04728893· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Fut, nem toboroz

  Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL)

  NCT04608318· 3. fázis· German CLL Study Group· Forrás

• Toboroz

  Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

  NCT04613596· 2/3. fázis· Mirati Therapeutics Inc.· Forrás

Showing 50 of 65.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Epilepszia3 toboroz
• Idiopátiás tüdőfibrózis3 toboroz
• 2-es típusú cukorbetegség2 toboroz
• Crohn-betegség2 toboroz
• Időskori makuladegeneráció2 toboroz
• Krónikus vesebetegség2 toboroz
• Szívelégtelenség2 toboroz
• 1-es típusú cukorbetegség1 toboroz
• Amiloidózis1 toboroz
• Áttétes emlőrák1 toboroz
• Coeliac disease1 toboroz
• Colitis ulcerosa1 toboroz
• Elhízás1 toboroz
• Hepatitis B (krónikus)1 toboroz
• Hepatitis C1 toboroz
• HIV-fertőzés1 toboroz
• Hólyagrák1 toboroz
• Koszorúér-betegség1 toboroz
• Krónikus limfoid leukémia (CLL)1 toboroz
• Krónikus obstruktív tüdőbetegség (COPD)1 toboroz
• Magas vérnyomás1 toboroz
• Peripheral artery disease1 toboroz
• Stroke (szélütés)1 toboroz
• Tüdőrák1 toboroz

Lezárt vizsgálatok

• Lezárult

  Study of Intra-articular Allocetra in Knee Osteoarthritis

  NCT06233474· 1/2. fázis· Enlivex Therapeutics Ltd.· Forrás

• Leállították

  Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis

  NCT06097260· 2. fázis· Pliant Therapeutics, Inc.· Forrás

• Lezárult

  Observational Study of Adult Participants With Diabetic Macular Edema and Suboptimal Response to Anti-Vascular Endothelial Growth Factor Treated With Dexamethasone Intravitreal Implant

  NCT05978622· AbbVie· Forrás

• Visszavonták

  A Study to Investigate Leramistat in Patients With IPF

  NCT05951296· 2. fázis· Modern Biosciences Ltd· Forrás

• Lezárult

  Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM

  NCT05767346· 3. fázis· Cytokinetics· Forrás

• Lezárult

  To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF

  NCT05483907· 2. fázis· Bridge Biotherapeutics, Inc.· Forrás

• Lezárult

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Effectiveness and Safety of CCoat Intra-Articular Injections in Mild to Moderate Knee Osteoarthritis

  NCT05771948· Lipo-Sphere· Forrás

• Lezárult

  A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC

  NCT05611671· 2. fázis· Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)· Forrás

• Lezárult

  Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy

  NCT05536297· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás

• Lezárult

  Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

  NCT05255991· 3. fázis· United Therapeutics· Forrás

• Lezárult

  Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM

  NCT05186818· 3. fázis· Cytokinetics· Forrás

• Lezárult

  A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)

  NCT04945460· 2. fázis· Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA· Forrás

• Lezárult

  A Study to Investigate Vamikibart (RO7200220) in Combination With Ranibizumab in Diabetic Macular Edema

  NCT05151744· 2. fázis· Hoffmann-La Roche· Forrás

• Leállították

  The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis

  NCT04985968· 3. fázis· InDex Pharmaceuticals· Forrás

• Lezárult

  A Study to Assess Real-World Use, Safety, and Effectiveness of Oral Upadacitinib in Adult and Adolescent (>=12 Years Old) Participants With Atopic Dermatitis

  NCT05081557· AbbVie· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

  NCT05037929· 2. fázis· Genentech, Inc.· Forrás

• Lezárult

  A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease

  NCT05047263· 3. fázis· Bayer· Forrás

• Leállították

  To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304)

  NCT04551053· 3. fázis· Incyte Corporation· Forrás

• Leállították

  To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)

  NCT04551066· 3. fázis· Incyte Corporation· Forrás

• Lezárult

  The Effect of Ultrasound Guided Visual Biofeedback Performed by Midwifes on the Duration of the Active Second Stage of Labor

  NCT06857552· Kaplan Medical Center· Forrás

• Lezárult

  A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial

  NCT04847557· 3. fázis· Eli Lilly and Company· Forrás

• Lezárult

  A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

  NCT04777201· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

  NCT04509674· 3. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  Study Of Oral Elagolix Tablets To Assess the Tolerability and Change in Disease Symptoms in Adult Female Participants With Moderate to Severe Endometriosis-associated Pain

  NCT04630990· AbbVie· Forrás

• Lezárult

  Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%

  NCT04435626· 3. fázis· Bayer· Forrás

• Lezárult

  Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye

  NCT04423718· 3. fázis· Bayer· Forrás

• Lezárult

  A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

  NCT04255433· 3. fázis· Eli Lilly and Company· Forrás

• Lezárult

  CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

  NCT04136171· 3. fázis· Ionis Pharmaceuticals, Inc.· Forrás

• Lezárult

  Study of Doravirine/Islatravir (DOR/ISL 100 mg/0.75 mg) to Evaluate the Antiretroviral Activity, Safety, and Tolerability in Treatment-Naïve Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-020)

  NCT04233879· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression

  NCT04209855· 3. fázis· AbbVie· Forrás

• Lezárult

  A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease

  NCT03819153· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]

  NCT03734029· 3. fázis· Daiichi Sankyo· Forrás

• Lezárult

  A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT03524092· 3. fázis· Eli Lilly and Company· Forrás

• Lezárult

  An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

  NCT03518086· 3. fázis· Eli Lilly and Company· Forrás

• Lezárult

  Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

  NCT03473223· 3. fázis· CSL Behring· Forrás

• Lezárult

  Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)

  NCT03364153· 2. fázis· Astellas Pharma Global Development, Inc.· Forrás

• Lezárult

  Standard Chemoimmunotherapy (FCR/BR) Versus Rituximab + Venetoclax (RVe) Versus Obinutuzumab (GA101) + Venetoclax (GVe) Versus Obinutuzumab + Ibrutinib + Venetoclax (GIVe) in Fit Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without Del(17p) or TP53 Mutation

  NCT02950051· 3. fázis· German CLL Study Group· Forrás

• Lezárult

  A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease

  NCT02620046· 3. fázis· Takeda· Forrás

• Lezárult

  Avelumab in First-line NSCLC (JAVELIN Lung 100)

  NCT02576574· 3. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Lezárult

  A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer

  NCT02163694· 3. fázis· AbbVie· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Peripheral artery disease6 munka · 3 vizsgálat